US lawFederal (United States)Session lawPub. L. 112-144 — To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.102Pub. L. 112-144, tit. I, sec. 102DEFINITIONS.EnactedYear: 2012Length: 23 wordsOfficial source SEC. 102. DEFINITIONS. Section 735(7) (21 U.S.C. 379g) is amended by striking “expenses incurred in connection with” and inserting “expenses in connection with”.PreviousPub. L. 112-144, tit. I, sec. 101NextPub. L. 112-144, tit. I, sec. 103